Evidence map›Paper›PMID 28876128›Full record

ArticleHigh altitude medicine & biology2017

Influence of Inhaled Amiloride on Lung Fluid Clearance in Response to Normobaric Hypoxia in Healthy Individuals.

Courtney M Wheatley, Sarah E Baker, Bryan J Taylor, Manda L Keller-Ross, Steven C Chase, Alex R Carlson, Robert J Wentz, Eric M Snyder, Bruce D Johnson

Abstract read
In one paragraph

Article in High altitude medicine & biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Courtney M Wheatley1 Department of Pharmaceutical Science, University of Arizona , Tucson, Arizona.
Sarah E Baker1 Department of Pharmaceutical Science, University of Arizona , Tucson, Arizona.
Bryan J Taylor2 Division of Cardiovascular Diseases, Mayo Clinic , Rochester, Minnesota.
Manda L Keller-Ross2 Division of Cardiovascular Diseases, Mayo Clinic , Rochester, Minnesota.
Steven C Chase2 Division of Cardiovascular Diseases, Mayo Clinic , Rochester, Minnesota.
Alex R Carlson2 Division of Cardiovascular Diseases, Mayo Clinic , Rochester, Minnesota.
Robert J Wentz2 Division of Cardiovascular Diseases, Mayo Clinic , Rochester, Minnesota.
Eric M Snyder1 Department of Pharmaceutical Science, University of Arizona , Tucson, Arizona.
Bruce D Johnson2 Division of Cardiovascular Diseases, Mayo Clinic , Rochester, Minnesota.

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
NCATS NIH HHS UL1 TR000135
6 · The paper itself

Abstract

Wheatley, Courtney M., Sarah E. Baker, Bryan J. Taylor, Manda L. Keller-Ross, Steven C. Chase, Alex R. Carlson, Robert J. Wentz, Eric M. Snyder, and Bruce D. Johnson. Influence of inhaled amiloride on lung fluid clearance in response to normobaric hypoxia in healthy individuals. High Alt Med Biol 18:343-354, 2017.

aimTo investigate the role of epithelial sodium channels (ENaC) on lung fluid clearance in response to normobaric hypoxia, 20 healthy subjects were exposed to 15 hours of hypoxia (fraction of inspired oxygen [FiO

resultsNormobaric hypoxia caused (1) a reduction in EVLW (change from baseline for A vs. P, -8.5% ± 3.8% vs. -7.9% ± 5.2%, p < 0.05), (2) an increase in V

conclusionAcute normobaric hypoxia caused a reduction in lung fluid that was unaffected by ENaC inhibition through inhaled amiloride. Although possible amiloride-sensitive ENaC may not be necessary to maintain lung fluid balance in response to hypoxia, it is more probable that normobaric hypoxia promotes lung fluid clearance rather than accumulation for the majority of healthy individuals. The observed reduction in interstitial lung fluid means alveolar fluid clearance may not have been challenged.

Indexed as

Administration, InhalationAdultAmilorideAtmospheric PressureBlood VolumeEpithelial Sodium Channel BlockersEpithelial Sodium ChannelsExtravascular Lung WaterFemaleFluid ShiftsHealthy VolunteersHumansHypoxiaLungMalePulmonary Diffusing CapacityAmilorideEpithelial Sodium Channel BlockersEpithelial Sodium Channelschest computed tomography (CT)diffusion capacity of the lungs for carbon monoxide and nitric oxide (DLCO/DLNO)epithelial sodium channels (ENaC)

Identifiers

PMID28876128
PMCPMC5743027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.